JAK抑制剂治疗儿童斑秃的研究进展  

Update of JAK inhibitors in the treatment of alopecia areata in children

作　　者：张兰 史冬梅[2] 王玮[2] ZHANG Lan;SHI Dongmei;WANG Wei(Jining Medical College,Jining 273500,China;Department of Dermatology,Jining first people s Hospital,Jining 272067,China)

机构地区：[1]济宁医学院,山东济宁272067 [2]济宁市第一人民医院皮肤科,山东济宁272000

出　　处：《中国麻风皮肤病杂志》2023年第2期138-141,共4页China Journal of Leprosy and Skin Diseases

基　　金：山东省中医药科技项目面上项目(编号:2021M080)。

摘　　要：斑秃(AA)是一种常见的非瘢痕性脱发,儿童斑秃预后不佳、病情易反复,可严重影响患者及家长的心理健康和生活质量。近年来,人们逐渐发现酪氨酸蛋白激酶(JAK)/信号转导与转录激活因子(STAT)信号通路在斑秃的发病机制中起着重要作用。目前已有多篇病例报告和小型临床试验报道JAK抑制剂治疗儿童斑秃的有效性及安全性,因此JAK抑制剂对于儿童中重度斑秃的治疗可能会成为一种新的选择。alopecia areata(AA)is a common non scar hair loss.The prognosis of AA in children is poor and the condition is easy to repeat,which can seriously affect the mental health and quality of life of patients and parents.In recent years,it has been gradually found that tyrosine protein kinase(JAK)/signal transducer and activator of transcription(STAT)signaling pathway plays an important role in the pathogenesis of AA.At present,many case reports and small clinical trials have reported the efficacy and safety of JAK inhibitors in the treatment of childhood alopecia areata.Therefore,JAK inhibitors may become a new choice for the treatment of moderate and severe AA in children.

关 键 词：JAK抑制剂 斑秃 儿童 

分 类 号：R758.71[医药卫生—皮肤病学与性病学]